α-D-Mannopyranoside, 2-propen-1-yl

Catalog No.: 
ACYFEZ140
CAS No.: 
41308-76-3
Molecular Formula: 
C9H16O6
Molecular Weight: 
220.22
α-D-Mannopyranoside, 2-propen-1-yl structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg95%$118.00InquiryInquiry
10mg95%$157.00InquiryInquiry
25mg95%$265.00InquiryInquiry
50mg95%$398.00InquiryInquiry
100mg95%$573.00InquiryInquiry
250mg95%$922.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nameα-D-Mannopyranoside, 2-propen-1-yl
IUPAC Name(2S,3S,4S,5S,6R)-2-(allyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
MDL No.MFCD08274515
Molecular FormulaC9H16O6
Molecular Weight220.22
SMILESO[C@@H]1[C@@H](OCC=C)O[C@H](CO)[C@@H](O)[C@@H]1O
InChI KeyXJNKZTHFPGIJNS-DFTQBPQZSA-N
Synonym2-Propenyl α-D-mannopyranoside
CAS No.41308-76-3
PubChem CID11183597

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYFEZ140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNOLX072 route compound structure diagram
    ACNOLX0723458-28-4In Stock
  2. Then
  3. ACYFEZ140 route product structure diagram
    ACYFEZ14041308-76-3
Inquiry

2. ACYFEZ140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYFEZ140 route product structure diagram
    ACYFEZ14041308-76-3
Inquiry

3. ACYFEZ140 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYFEZ140 route product structure diagram
    ACYFEZ14041308-76-3
Inquiry

Comments (0)